Assessing responsiveness over time of the PROMIS® pediatric symptom and function measures in cancer, nephrotic syndrome, and sickle cell disease

@article{Reeve2017AssessingRO,
  title={Assessing responsiveness over time of the PROMIS® pediatric symptom and function measures in cancer, nephrotic syndrome, and sickle cell disease},
  author={Bryce B Reeve and Lloyd J. Edwards and Byron C. Jaeger and Pamela S. Hinds and Carlton D. Dampier and Debbie S. Gipson and David T. Selewski and Jonathan P. Troost and David M Thissen and V Barry and Heather E. Gross and Darren A. Dewalt},
  journal={Quality of Life Research},
  year={2017},
  volume={27},
  pages={249-257}
}
Previous studies provided evidence for the validity of the PROMIS Pediatric measures in cross-sectional studies. This study evaluated the ability of the PROMIS Pediatric measures to detect change over time in children and adolescents with cancer, nephrotic syndrome (NS), or sickle cell disease (SCD). Participants (8–17 years) completed measures of fatigue… CONTINUE READING